Practical clinical application of biochemical markers of bone turnover - Consensus of an Expert Panel

被引:85
作者
Miller, PD
Baram, DT
Bilezikian, JP
Greenspan, SL
Lindsay, R
Riggs, BL
Watts, NB
机构
[1] Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA
[2] Colorado Ctr Bone Res, Denver, CO 80262 USA
[3] Univ Massachusetts, Med Ctr, Dept Orthopaed Endocrinol & Metab, Worcester, MA USA
[4] Columbia Univ, Coll Phys & Surg, Dept Med & Pharmacol, New York, NY USA
[5] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA USA
[6] Harvard Univ, Sch Med, Boston, MA USA
[7] Columbia Univ, Dept Med, New York, NY USA
[8] Helen Hayes Hosp, Reg Bone Ctr, W Haverstraw, NY USA
[9] Mayo Clin & Mayo Fdn, Div Endocrinol Metab & Internal Med, Rochester, MN 55905 USA
[10] Emory Univ, Sch Med, Div Endocrinol, Atlanta, GA USA
[11] Emory Clin, Atlanta, GA 30322 USA
关键词
D O I
10.1385/JCD:2:3:323
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Biochemical markers of bone turnover have emerged as powerful tools to aid in managing osteoporosis. The newer bone markers have been intensively studied for more than a decade. As a result, we can now confidently report their clinical utility in assessing risk of rapid bone loss and fracture, and monitoring therapy in postmenopausal women with or at risk of osteoporosis. In this review, we will provide a comprehensive foundation for this utility. While there are still questions remaining to be answered, bone marker technology has matured to play an essential role in patient management. We will describe, in practical terms, how bone markers can be appropriately incorporated into clinical practice today.
引用
收藏
页码:323 / 342
页数:20
相关论文
共 180 条
[1]   EFFECTS OF ORAL ALENDRONATE AND INTRANASAL SALMON-CALCITONIN ON BONE MASS AND BIOCHEMICAL MARKERS OF BONE TURNOVER IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS [J].
ADAMI, S ;
PASSERI, M ;
ORTOLANI, S ;
BROGGINI, M ;
CARRATELLI, L ;
CARUSO, I ;
GANDOLINI, G ;
GNESSI, L ;
LAURENZI, M ;
LOMBARDI, A ;
NORBIATO, G ;
PRYORTILLOTSON, S ;
REDA, C ;
ROMANINI, L ;
SUBRIZI, D ;
WEI, L ;
YATES, AJ .
BONE, 1995, 17 (04) :383-390
[2]   THE EFFECT OF MENOPAUSE AND HORMONE REPLACEMENT THERAPY ON BONE ALKALINE-PHOSPHATASE [J].
ALEXANDERSEN, P ;
HASSAGER, C ;
RIIS, BJ .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1995, 55 (07) :571-576
[3]   Biochemical and hormonal variables in black and white women matched for age and weight [J].
Aloia, JF ;
Mikhail, M ;
Pagan, CD ;
Arunacha-Lam, A ;
Yeh, JK ;
Flaster, E .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1998, 132 (05) :383-389
[4]   Differential effects of dietary calcium augmentation and hormone replacement therapy on bone turnover and serum levels of calcitrophic hormones [J].
Aloia, JF ;
Vaswani, A ;
Yeh, JK ;
Russo, L .
OSTEOPOROSIS INTERNATIONAL, 1996, 6 (01) :55-62
[5]  
ALVAREZ L, 1995, J BONE MINER RES, V10, P458
[6]  
[Anonymous], 1994, World Health Organ Tech Rep Ser, V843, P1
[7]  
Aoyagi K, 1997, J BONE MINER RES, V12, pS638
[8]   Diagnosis and management of osteoporosis: Guidelines for the utilization of bone densitometry [J].
Baran, DT ;
Faulkner, KG ;
Genant, HK ;
Miller, PD ;
Pacifici, R .
CALCIFIED TISSUE INTERNATIONAL, 1997, 61 (06) :433-440
[9]   Short-term variations in bone remodeling biochemical markers: Cyclical etidronate and alendronate effects compared [J].
Bettica, P ;
Bevilacqua, M ;
Vago, T ;
Masino, M ;
Cucinotta, E ;
Norbiato, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (09) :3034-3039
[10]   Biochemical markers in the assessment of bone disease [J].
Bikle, DD .
AMERICAN JOURNAL OF MEDICINE, 1997, 103 (05) :427-436